3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Tranexamic Acid
13
Sodium Chloride
4
Misoprostol
4
Saline Solution
3
Enoxaparin
3
carbetocin
2
Tourniquets
2
Ringer's Lactate
2
Oxytocin
2
Endoscopic Mucosal Resection
2
Dalteparin
2
maleimide-polyethylene glycol-modified hemoglobin, MP4
1
bemiparin
1
Vitamin B 6
1
Vasopressins
1
Uterine Myomectomy
1
Uterine Artery Embolization
1
Tinzaparin
1
Thoracic Surgery, Video-Assisted
1
Terlipressin
1
Sutures
1
Surgicel
1
Standard of Care
1
Solutions
1
Sensitivity Training Groups
1
Rivaroxaban
1
Ringer's Solution
1
Radiotherapy
1
Proton Pump Inhibitors
1
Palliative Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hemorrhage
×
N(4)-oleylcytosine arabinoside
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled